77 completed, 6 terminated, 5 unknown, 4 not yet recruiting. 95 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 95 | Completed 77, Terminated 6, Unknown 5, Not yet recruiting 4, Withdrawn 2, Recruiting 1 |
| Phase 2 | 3 | Completed 3 |
Follow Contraception: new trials by email Literature Review of Contraception trials Research Report on Contraception
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Contraceptive Efficacy and Safety of a New Concentration of an Antiandrogenic Progestogen Combined With a Reduced-Dose Estrogen (LUNA) Cyproterone Acetate 2 mg and Ethinyl Estradiol 0.02 mg - Contraception | Phase 3 | Not yet recruiting | Eurofarma Laboratorios S.A. | 1600 | 2027-05-31 | 2026-10-23 |
| Rct Assessing Pregnancy - Piroxicam for Ec With Levonorgestrel Levonorgestrel 1.5 mg and Piroxicam 40 mg, Oral LNG + Placebo - Emergency Contraception, Contraception | Phase 3 | Not yet recruiting | University of Utah | 1458 | 2027-03-01 | 2026-03-04 |
| Arterial Vascular Effects of Estetrol-drospirenone Combined Oral Contraceptive Pill Estetrol-drospirenone, Ethinylestradiol-levonorgestrel - Contraception | Phase 3 | Not yet recruiting | Dr. Hang Wun Raymond Li | 98 | 2026-07-01 | 2026-04-27 |
| Evaluation of the Efficacy, Safety, and Tolerability of LevoCept LevoCept - Contraception, Women at Risk for Pregnancy | Phase 3 | Not yet recruiting | Sebela Women's Health Inc. | 1525 | 2026-06-01 | 2025-05-22 |
| Levonorgestrel-piroxicam Versus Ulipristal Acetate for Emergency Contraception Levonorgestrel, Piroxicam, Ulipristal Acetate - Contraception | Phase 3 | Recruiting | The University of Hong Kong | 980 | 2025-01-18 | 2026-05-14 |
| A Trial of Efficacy, Safety and Tolerability of LVDS (Levonorgestrel Vaginal Delivery System) During 13 Cycles LVDS - Contraception | Phase 3 | Completed | Chemo Research | 1039 | 2023-08-09 | 2026-04-21 |
| Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females Drospirenone - Contraception, Change in Bone Mineral Density | Phase 3 | Completed | Insud Pharma | 1542 | 2022-08-02 | 2025-10-08 |
| Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive NOMAC-E2 COC - Contraception | Phase 3 | Terminated | Organon and Co | 3055 | 2022-02-17 | 2025-11-21 |
| Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles MR-100A-01 - Contraception | Phase 3 | Completed | Mylan Technologies Inc. | 1320 | 2021-10-26 | 2026-09-14 |
| Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy Relugolix Combination Therapy - Contraception | Phase 3 | Completed | Sumitomo Pharma Switzerland GmbH | 1164 | 2021-03-18 | 2026-05-13 |
| A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060) Radiopaque Etonogestrel (ENG) Implant - Contraception | Phase 3 | Completed | Organon and Co | 498 | 2020-11-19 | 2026-02-18 |
| Comparative Efficacy of Lidocaine Spray Versus Vaginal Misoprostol in IUD Insertion lidocaine spray, vaginal misoprostol, placebo - Contraception | Phase 3 | Completed | Cairo University | 147 | 2020-05-01 | 2021-12-10 |
| Comparative Safety and Efficacy of Vaginal Misoprostol Versus Lidocaine-prilocaine Cream in Levonorgestrel IUD Insertion vaginal misoprostol, Lidocaine-Prilocaine Topical cream, placebo - Contraception | Phase 3 | Completed | Cairo University | 210 | 2020-04-30 | 2021-05-07 |
| Comparative Safety and Efficacy of Vaginal Dinoprostone Versus Lidocaine-prilocaine Cream in Copper IUD Insertion vaginal dinoprostone, Lidocaine-prilocaine Cream, placebo - Contraception | Phase 3 | Unknown | Cairo University | 210 | 2020-04-30 | 2020-04-10 |
| Effect of Oral Tramadol Administration Prior to IUD Insertion oral tramadol, Placebo oral tablet - Contraception | Phase 3 | Unknown | Cairo University | 108 | 2020-03-30 | 2020-03-18 |
| Safety and Efficacy of the Effect of Isosorbide Mononitrate in Reducing Pain During Levonorgestrel-releasing Intrauterine Device Insertion Isosorbide Mononitrate 40 MG, Placebo - Contraception | Phase 3 | Unknown | Cairo University | 88 | 2020-03-30 | 2020-03-17 |
| A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles LPRI424 (dienogest/ethinylestradiol) - Contraception | Phase 3 | Completed | Insud Pharma | 1034 | 2019-12-03 | 2023-11-14 |
| Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use Norgestrel 0.075 mg tablets - Contraception | Phase 3 | Completed | HRA Pharma | 962 | 2019-09-06 | 2022-05-20 |
| A Study of Oral Contraception Under Simulated OTC Conditions Norgestrel 0.075 mg tablets - Contraception | Phase 3 | Terminated | HRA Pharma | 189 | 2018-04-27 | 2022-04-04 |
| Sayana® Press Extension Study Sayana® Press - Contraception | Phase 3 | Completed | FHI 360 | 750 | 2017-09-22 | 2024-08-30 |
Showing 20 of 95. Sign in to see all of them.
Hemorrhage (2) · Neural Tube Defects (2) · Contraception Behavior (1) · Endometriosis (1) · Leiomyoma (1) · Menorrhagia (1) · Patient Compliance (1) · Sexual Dysfunction, Physiological (1)
Genital Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Urogenital Diseases (3) · Behavior (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases, Female (2) · Nervous System Diseases (2) · Nervous System Malformations (2) · Health Behavior (1) · Hemorrhage (1) · Menstruation Disturbances (1)
Ethinyl Estradiol (15) · Levonorgestrel (10) · drospirenone and ethinyl estradiol combination (9) · drospirenone (8) · Ethinyl Estradiol-Norgestrel Combination (5) · etonogestrel (4) · norelgestromin (4) · Contraceptive Devices, Female (3) · Estradiol (3) · ethinyl estradiol, levonorgestrel drug combination (3) · Endoglin (2) · Estetrol (2) · Gestodene (2) · Norethindrone Acetate (2) · Norgestrel (2)
Bayer (31) · Organon and Co (14) · Cairo University (5) · Duramed Research (3) · HRA Pharma (3) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (3) · Agile Therapeutics (2) · Assiut University (2) · Estetra (2) · Evofem Inc. (2) · Insud Pharma (2) · Warner Chilcott (2) · Ain Shams University (1) · CONRAD (1) · Chemo Research (1)
United States (40) · Germany (10) · Austria (8) · Canada (8) · Finland (7) · France (6) · Spain (6) · Australia (5) · Egypt (5) · Netherlands (5) · Sweden (5) · Belgium (4) · Brazil (4) · Chile (4) · China (4)
Enrico Colli, MD (3) · Alfred Poindexter, MD (1) · Andrea Olariu, MD, PhD (1) · Anna F Glasier, MD (1) · Brian T Nguyen, MD, MSc (1) · David Archer, MD (1) · David Turok, MD, MPH (1) · Diana L. Blithe, PH.D. (1)
PMID 11849631, PMID 11849634, PMID 21277674, PMID 21721590, PMID 25712537, PMID 26267119, PMID 31231065, PMID 31398307, PMID 37023457, PMID 38295968, PMID 11704172, PMID 19835717, PMID 20004272, PMID 20116841, PMID 20695770, PMID 21074011, PMID 21663597, PMID 21903192, PMID 21995590, PMID 22066891, PMID 22067790, PMID 22281416, PMID 22454003, PMID 22454004, PMID 22525910, PMID 22540269, PMID 22762147, PMID 22939402, PMID 23493606, PMID 23534865, PMID 23638631, PMID 23921878, PMID 24034466, PMID 24105751, PMID 24240244, PMID 24402597, PMID 24726226, PMID 24993487, PMID 25453582, PMID 25453585, PMID 25582984, PMID 25586864, PMID 25661510, PMID 25751199, PMID 25880636, PMID 25934164, PMID 26378938, PMID 26410176, PMID 26872720, PMID 26965870
2008 (3), 2004 (1), 2005 (1), 2014 (1)